Cargando…

Microvascular permeability during experimental human endotoxemia: an open intervention study

INTRODUCTION: Septic shock is associated with increased microvascular permeability. As a model for study of the pathophysiology of sepsis, endotoxin administration to humans has facilitated research into inflammation, coagulation and cardiovascular effects. The present study was undertaken to determ...

Descripción completa

Detalles Bibliográficos
Autores principales: van Eijk, Lucas TGJ, Pickkers, Peter, Smits, Paul, Broek, Wim van den, Bouw, Martijn PWJM, van der Hoeven, Johannes G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175929/
https://www.ncbi.nlm.nih.gov/pubmed/15774049
http://dx.doi.org/10.1186/cc3050
_version_ 1782124542370512896
author van Eijk, Lucas TGJ
Pickkers, Peter
Smits, Paul
Broek, Wim van den
Bouw, Martijn PWJM
van der Hoeven, Johannes G
author_facet van Eijk, Lucas TGJ
Pickkers, Peter
Smits, Paul
Broek, Wim van den
Bouw, Martijn PWJM
van der Hoeven, Johannes G
author_sort van Eijk, Lucas TGJ
collection PubMed
description INTRODUCTION: Septic shock is associated with increased microvascular permeability. As a model for study of the pathophysiology of sepsis, endotoxin administration to humans has facilitated research into inflammation, coagulation and cardiovascular effects. The present study was undertaken to determine whether endotoxin administration to human volunteers can be used as a model to study the sepsis-associated increase in microvascular permeability. METHODS: In an open intervention study conducted in a university medical centre, 16 healthy volunteers were evaluated in the research unit of the intensive care unit. Eight were administered endotoxin intravenously (2 ng/kg Escherichia coli O113) and eight served as control individuals. Microvascular permeability was assessed before and 5 hours after the administration of endotoxin (n = 8) or placebo (n = 8) by three different methods: transcapillary escape rate of I(125)-albumin; venous occlusion strain-gauge plethysmography to determine the filtration capacity; and bioelectrical impedance analysis to determine the extracellular and total body water. RESULTS: Administration of endotoxin resulted in the expected increases in proinflammatory cytokines, temperature, flu-like symptoms and cardiovascular changes. All changes were significantly different from those in the control group. In the endotoxin group all microvascular permeability parameters remained unchanged from baseline: transcapillary escape rate of I(125)-albumin changed from 7.2 ± 0.6 to 7.7 ± 0.9%/hour; filtration capacity changed from 5.0 ± 0.3 to 4.2 ± 0.4 ml/min per 100 ml mmHg × 10(-3); and extracellular/total body water changed from 0.42 ± 0.01 to 0.40 ± 0.01 l/l (all differences not significant). CONCLUSION: Although experimental human endotoxaemia is frequently used as a model to study sepsis-associated pathophysiology, an endotoxin-induced increase in microvascular permeability in vivo could not be detected using three different methods. Endotoxin administration to human volunteers is not suitable as a model in which to study changes in microvascular permeability.
format Text
id pubmed-1175929
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-11759292005-07-17 Microvascular permeability during experimental human endotoxemia: an open intervention study van Eijk, Lucas TGJ Pickkers, Peter Smits, Paul Broek, Wim van den Bouw, Martijn PWJM van der Hoeven, Johannes G Crit Care Research INTRODUCTION: Septic shock is associated with increased microvascular permeability. As a model for study of the pathophysiology of sepsis, endotoxin administration to humans has facilitated research into inflammation, coagulation and cardiovascular effects. The present study was undertaken to determine whether endotoxin administration to human volunteers can be used as a model to study the sepsis-associated increase in microvascular permeability. METHODS: In an open intervention study conducted in a university medical centre, 16 healthy volunteers were evaluated in the research unit of the intensive care unit. Eight were administered endotoxin intravenously (2 ng/kg Escherichia coli O113) and eight served as control individuals. Microvascular permeability was assessed before and 5 hours after the administration of endotoxin (n = 8) or placebo (n = 8) by three different methods: transcapillary escape rate of I(125)-albumin; venous occlusion strain-gauge plethysmography to determine the filtration capacity; and bioelectrical impedance analysis to determine the extracellular and total body water. RESULTS: Administration of endotoxin resulted in the expected increases in proinflammatory cytokines, temperature, flu-like symptoms and cardiovascular changes. All changes were significantly different from those in the control group. In the endotoxin group all microvascular permeability parameters remained unchanged from baseline: transcapillary escape rate of I(125)-albumin changed from 7.2 ± 0.6 to 7.7 ± 0.9%/hour; filtration capacity changed from 5.0 ± 0.3 to 4.2 ± 0.4 ml/min per 100 ml mmHg × 10(-3); and extracellular/total body water changed from 0.42 ± 0.01 to 0.40 ± 0.01 l/l (all differences not significant). CONCLUSION: Although experimental human endotoxaemia is frequently used as a model to study sepsis-associated pathophysiology, an endotoxin-induced increase in microvascular permeability in vivo could not be detected using three different methods. Endotoxin administration to human volunteers is not suitable as a model in which to study changes in microvascular permeability. BioMed Central 2005 2005-02-21 /pmc/articles/PMC1175929/ /pubmed/15774049 http://dx.doi.org/10.1186/cc3050 Text en Copyright © 2005 van Eijk et al.; licensee BioMed Central Ltd.
spellingShingle Research
van Eijk, Lucas TGJ
Pickkers, Peter
Smits, Paul
Broek, Wim van den
Bouw, Martijn PWJM
van der Hoeven, Johannes G
Microvascular permeability during experimental human endotoxemia: an open intervention study
title Microvascular permeability during experimental human endotoxemia: an open intervention study
title_full Microvascular permeability during experimental human endotoxemia: an open intervention study
title_fullStr Microvascular permeability during experimental human endotoxemia: an open intervention study
title_full_unstemmed Microvascular permeability during experimental human endotoxemia: an open intervention study
title_short Microvascular permeability during experimental human endotoxemia: an open intervention study
title_sort microvascular permeability during experimental human endotoxemia: an open intervention study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175929/
https://www.ncbi.nlm.nih.gov/pubmed/15774049
http://dx.doi.org/10.1186/cc3050
work_keys_str_mv AT vaneijklucastgj microvascularpermeabilityduringexperimentalhumanendotoxemiaanopeninterventionstudy
AT pickkerspeter microvascularpermeabilityduringexperimentalhumanendotoxemiaanopeninterventionstudy
AT smitspaul microvascularpermeabilityduringexperimentalhumanendotoxemiaanopeninterventionstudy
AT broekwimvanden microvascularpermeabilityduringexperimentalhumanendotoxemiaanopeninterventionstudy
AT bouwmartijnpwjm microvascularpermeabilityduringexperimentalhumanendotoxemiaanopeninterventionstudy
AT vanderhoevenjohannesg microvascularpermeabilityduringexperimentalhumanendotoxemiaanopeninterventionstudy